The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

NCT01676116 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

438

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec/liraglutide
DRUG: liraglutide
DRUG: exenatide

Sponsor

Novo Nordisk A/S